688235.SS
Price:
$250.51
Market Cap:
$38.62B
BeOne Medicines AG, an oncology-focused enterprise headquartered in Basel, Switzerland, was established in 2010. This company is actively involved in the exploration and advancement of a diverse range of therapeutic solutions for cancer patients across key global regions, including the United States, China, Europe, and other international markets. Its current commercial portfolio features several significant treatments: BRUKINSA: A small molecule designed to inhibit Bruton's Tyrosine Kinase (BTK), indicated for various blood cancers. TEVIMBRA: An anti-PD-1 antibody immunotherapy utilized in the treatment of both solid tumors and blood cancers. PARTRUVIX: A selective small molecule inhibitor ...[Read more]
Industry
Biotechnology
IPO Date
2021-12-15
Stock Exchange
SHH
Ticker
688235.SS
According to BeOne Medicines Ltd. Class A’s latest financial reports and current stock price. The company's current Enterprise Value is 35.83B. This represents a change of 40.20% compared to the average of 25.55B of the last 4 quarters.
The mean historical Enterprise Value of BeOne Medicines Ltd. Class A over the last ten years is 5.33B. The current 35.83B Enterprise Value has changed 67.06% with respect to the historical average. Over the past ten years (40 quarters), 688235.SS's Enterprise Value was at its highest in in the December 2025 quarter at 52.69B. The Enterprise Value was at its lowest in in the June 2022 quarter at -2374613894.94.
Average
5.33B
Median
778.79M
Minimum
-1570817496.85
Maximum
50.95B
Discovering the peaks and valleys of BeOne Medicines Ltd. Class A Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.48%
Maximum Annual Enterprise Value = 50.95B
Minimum Annual Increase = -503.75%
Minimum Annual Enterprise Value = -1570817496.85
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 50.95B | 6.48% |
| 2024 | 774.41M | -503.75% |
| 2023 | -191801733.32 | -85.17% |
| 2022 | -1293422472.23 | -17.66% |
| 2021 | -1570817496.85 | -226.82% |
| 2020 | 1.24B | 18.23% |
| 2019 | 1.05B | 33.76% |
| 2018 | 783.18M | -18.27% |
| 2017 | 958.27M | 47.54% |
| 2016 | 649.49M | 203.75% |
The current Enterprise Value of BeOne Medicines Ltd. Class A (688235.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
17.18B
5-year avg
9.73B
10-year avg
5.33B
BeOne Medicines Ltd. Class A’s Enterprise Value is less than WuXi AppTec Co., Ltd. (264.06B), less than Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (163.73B), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (34.11B), greater than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (31.34B), less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (39.21B), less than RemeGen Co. Ltd. Class A (65.17B), less than Shanghai Junshi Biosciences Co., Ltd. (37.81B), greater than Nanjing Vazyme Biotech Co., Ltd. (8.79B), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (33.26B), greater than Sinocelltech Group Limited (19.56B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 264.06B | $291.58B | |
| 163.73B | $181.18B | |
| 34.11B | $36.10B | |
| 31.34B | $29.19B | |
| 39.21B | $39.50B | |
| 65.17B | $64.20B | |
| 37.81B | $35.74B | |
| 8.79B | $8.73B | |
| 33.26B | $34.44B | |
| 19.56B | $17.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines Ltd. Class A using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BeOne Medicines Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BeOne Medicines Ltd. Class A's Enterprise Value?
What is the highest Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS)?
What is the 3-year average Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS)?
What is the 5-year average Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS)?
How does the current Enterprise Value for BeOne Medicines Ltd. Class A (688235.SS) compare to its historical average?